1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1513
2YOU T, YANG R, LYLES M F. Abdominal adipose tissue cytokinegene expression : relationship to obesity and metabolic risk factors[J]. Am J Physiol Endocrinol Metab, 2005, 288(4) :741-747.
3SAXENA N K, hepatic fibrosis : in steXlate cells Hepatol, 2002, IKEDA K, ROCKEY D C, et al. Leptin in evidence for increased collagen production and lean littermates of ob/ob mice [ J]. 35 : 762.
4CHITTURI S, FARRELL G, FROST L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity.'? [ J ]. Hepatol, 2002, 36(2) :403-409.
5DING X K, SAXENA N. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology [ J]. Am J Pathol,2005, 166: 1655-1669.
6CHITTURI S, ABEYGUNADEKERA S, FARRELL G C, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J]. Hepatol, 2002, 35: 373.
8UYGUN A, KADAYIFCI A, YESILOVA Z, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis[J]. Am J Gastroenterol, 2000, 95: 3584-3589.
9HUAN J N, LI J, HAN Y, et al. Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance[J]. J Biol Chem, 2003, 278: 45638-45650.
10FRUEBIS I, TSAO T S, JAVORSCHI S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J]. Proc Nail Acad Sci USA , 2001, 98 : 2005-2010.
7Tilg H.Adipocytokines in nonalcoholic fatty liver disease:key players reg-ulating steatosis,inflammation and fibrosis[J].Curr Pharm Des,2010;16(17):1893-5.
8Yang Q,Graham TE,Mody N,et al.Serum retinol binding protein 4 con-tributes to insulin resistance in obesity and type 2 diabetes[J].Nature,2005;436(7049):356-62.
9Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease inChina[J].J Hepatol,2009;50(1):204-10.
10Wu H,Jia W,Bao Y,et al.Serum retinol binding protein 4 and nonalco-holic fatty liver disease in patients with type 2 diabetes mellitus[J].Dia-betes Res Clin Pract,2008;79(2):185-90.
